Helicobacter pylori infection, chronic atrophic gastritis and riskof stomach and esophagus cancer: Results from the prospec tivepopulation-based ESTHER cohort study
A cohort study involving nearly 10,000 patients found that infection with H. Pylori in the presence of chronic atrophic gastritis was associated... Read More
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
In a trial involving 949 patients with 40 tumor types, including gastric cancer, a blood test from Guardant Health was as good... Read More
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication
A new study finds that patients with type 2 diabetes who are treated for H. Pylori infection face an increased risk of... Read More
New Combination Shows Early Promise in Gastric Cancer
A combo of the immuno-oncology drug Keytruda with the VEGFR-2 inhibitor Cyramza was well tolerated by gastric cancer patients in a phase... Read More
Vanderbilt team shows how stomach bug can trigger cancer
Researchers at Vanderbilt and the University of Michigan uncovered the mechanisms by which H. Pylori injects a cancer-promoting protein into the stomach’s... Read More
Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination With D2 Gastrectomy
A recent study found that the XELOX chemo regimen given before and after surgery in patients with locally advanced gastric cancer was... Read More
Perioperative FOLFIRINOX for Gastroesophageal Adenocarcinoma
In a trial, the chemotherapy regimen FOLFIRINOX produced response rates on par with FLOT and may be easier to tolerate, says Dan... Read More
Chemo-Refractory Gastric Cancer Treated With Toripalimab
In a trial of the investigational PD-1 antibody toripalimab, gastric cancer patients with a high tumor mutational burden showed superior overall survival... Read More
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
Adding Tykerb to chemotherapy in HER-2 positive gastric cancer patients was proven safe in a phase 2 trial
Gastric cancer rates higher among patients treated for H. pylori
A recent study showed that people who are treated for H. Pylori infections experience higher gastric cancer rates, but it’s unclear if... Read More
